In This Section      

Clinical Trials

Current Studies

The Pituitary Center is actively recruiting participants for the following studies:

A Phase 3, Multicenter Study Designed to Evaluate the Efficacy and Safety of a Long Acting Hgh Product (Mod-4023) in Adult Subjects with Growth Hormone Deficiency (Enrollment closed)

Condition: Adult Growth Hormone Deficiency
Interventions: Drug: MOD-4023; Other: Placebo
Principle Investigator:  Roberto Salvatori, MD

Treatment for Endogenous Cushing's Syndrome

Condition: Endogenous Cushing's Syndrome
Intervention: Drug: COR-003 (Levoketoconazole)
Principle Investigator:  Roberto Salvatori, MD

Safety and Efficacy of LCI699 for the Treatment of Patients With Cushing's Disease

Condition: Cushing's Disease
Intervention: Drug: LCI699
Principle Investigator:  Roberto Salvatori, MD

Learn more

To learn more about this clinical trial please visit:
If interested, contact the Study Coordinator at 410-502-0033 or Roberto Salvatori, MD, Principal Investigator at 410-955-3921.

Request an Appointment

Maryland Patients

To arrange evaluations and request appointments, patients can call 410-955-9270 to speak with an agent who can begin the scheduling process. Learn more.



Traveling for Care?

Whether you're crossing the country or the globe, we make it easy to access world-class care at Johns Hopkins.

Outside of Maryland (toll free)

Request an Appointment
Medical Concierge Services

International Patients

Request an Appointment
Medical Concierge Services

blue suitcase